NASDAQ:SQNM - Sequenom Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.39 +2.39 (+∞)
(As of 09/8/2016)
Previous Close$2.39
Today's Range$2.39 - $2.39
52-Week Range$0.82 - $2.53
VolumeN/A
Average Volume1.27 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Receive SQNM News and Ratings via Email

Sign-up to receive the latest news and ratings for SQNM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
Current SymbolNASDAQ:SQNM
CUSIP81733740
Phone+1-858-2029000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Sequenom (NASDAQ:SQNM) Frequently Asked Questions

What is Sequenom's stock symbol?

Sequenom trades on the NASDAQ under the ticker symbol "SQNM."

Has Sequenom been receiving favorable news coverage?

Headlines about SQNM stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sequenom earned a media sentiment score of 1.2 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.

What other stocks do shareholders of Sequenom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sequenom investors own include Illumina (ILMN), Arch Coal (ARCH), Potlatchdeltic (PCH), Synergy Pharmaceuticals (SGYP), Novocure (NVCR), LinnCo (LNCOQ), Conatus Pharmaceuticals (CNAT), DryShips (DRYS), La Jolla Pharmaceutical (LJPC) and Novavax (NVAX).

How do I buy shares of Sequenom?

Shares of SQNM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sequenom's stock price today?

One share of SQNM stock can currently be purchased for approximately $2.39.

What is Sequenom's official website?

The official website for Sequenom is https://www.sequenom.com/.

How can I contact Sequenom?

Sequenom's mailing address is 3595 John Hopkins Ct, SAN DIEGO, CA 92121-1121, United States. The biotechnology company can be reached via phone at +1-858-2029000.


MarketBeat Community Rating for Sequenom (NASDAQ SQNM)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  243 (Vote Outperform)
Underperform Votes:  180 (Vote Underperform)
Total Votes:  423
MarketBeat's community ratings are surveys of what our community members think about Sequenom and other stocks. Vote "Outperform" if you believe SQNM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SQNM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel